207 related articles for article (PubMed ID: 31117166)
1. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma.
Wei ST; Chiang JY; Wang HL; Lei FJ; Huang YC; Wang CC; Cho DY; Hsieh CH
Cancer Sci; 2023 Jan; 114(1):174-186. PubMed ID: 36106406
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of CXC chemokines in the glioblastoma microenvironment.
Li C; Deng H; Zhou Y; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
Life Sci; 2020 Nov; 261():118486. PubMed ID: 32976881
[TBL] [Abstract][Full Text] [Related]
4. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
5. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Clin Cancer Res; 2019 Jun; 25(12):3702-3717. PubMed ID: 30850359
[TBL] [Abstract][Full Text] [Related]
6. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
Augsten M; Hägglöf C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3414-9. PubMed ID: 19218429
[TBL] [Abstract][Full Text] [Related]
7. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
Sjöberg E; Augsten M; Bergh J; Jirström K; Östman A
Br J Cancer; 2016 May; 114(10):1117-24. PubMed ID: 27115465
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Augsten M; Sjöberg E; Frings O; Vorrink SU; Frijhoff J; Olsson E; Borg Å; Östman A
Cancer Res; 2014 Jun; 74(11):2999-3010. PubMed ID: 24710408
[TBL] [Abstract][Full Text] [Related]
10. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells.
He Z; You C; Zhao D
Biochem Biophys Res Commun; 2018 Jun; 500(3):569-576. PubMed ID: 29655792
[TBL] [Abstract][Full Text] [Related]
12. Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
Zeng J; Yang X; Cheng L; Liu R; Lei Y; Dong D; Li F; Lau QC; Deng L; Nice EC; Xie K; Huang C
J Transl Med; 2013 Jan; 11():6. PubMed ID: 23294544
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.
Song EY; Shurin MR; Tourkova IL; Gutkin DW; Shurin GV
Cancer Res; 2010 Jun; 70(11):4394-401. PubMed ID: 20460540
[TBL] [Abstract][Full Text] [Related]
14. Expression and effect of CXCL14 in colorectal carcinoma.
Lin K; Zou R; Lin F; Zheng S; Shen X; Xue X
Mol Med Rep; 2014 Sep; 10(3):1561-8. PubMed ID: 24938992
[TBL] [Abstract][Full Text] [Related]
15. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
16. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
17. The cytokine gene CXCL14 restricts human trophoblast cell invasion by suppressing gelatinase activity.
Kuang H; Chen Q; Zhang Y; Zhang L; Peng H; Ning L; Cao Y; Duan E
Endocrinology; 2009 Dec; 150(12):5596-605. PubMed ID: 19833716
[TBL] [Abstract][Full Text] [Related]
18. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CXCL14 (BRAK) expression in prostate cancer.
Schwarze SR; Luo J; Isaacs WB; Jarrard DF
Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
[TBL] [Abstract][Full Text] [Related]
20. The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells.
McKinnon CM; Lygoe KA; Skelton L; Mitter R; Mellor H
Oncogene; 2008 Nov; 27(54):6856-65. PubMed ID: 18762809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
